{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T15:47:18Z","timestamp":1789055238019,"version":"build-2803163510"},"reference-count":59,"publisher":"Public Library of Science (PLoS)","issue":"7","license":[{"start":{"date-parts":[[2025,7,16]],"date-time":"2025-07-16T00:00:00Z","timestamp":1752624000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001804","name":"Canada Research Chairs","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001804","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009192","name":"Alberta Innovates","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100009192","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100015753","name":"Mental Health Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015753","id-type":"DOI","asserted-by":"publisher"}]},{"name":"MITACS Accelerate program"},{"name":"Simon & Martina Sochatsky Fund for Mental Health"},{"name":"Howard Berger Memorial Schizophrenia Research Fund"},{"name":"Abraham & Freda Berger Memorial Endowment Fund"},{"name":"Alberta Synergies in Alzheimer\u2019s and Related Disorders (SynAD) program"},{"DOI":"10.13039\/501100018911","name":"University Hospital Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100018911","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100000190","name":"University of Alberta","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100000190","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["www.plosmentalhealth.org"],"crossmark-restriction":false},"short-container-title":["PLOS Ment Health"],"abstract":"<jats:p>The opioid epidemic unfolded in three distinct waves, with the latest comprising of deaths attributed to illegally manufactured synthetic opioids. We discuss evidence for a 'silent epidemic' alongside the opioid epidemic comprising co-ingestion of stimulants including methamphetamine and cocaine. Data regarding opioid- and stimulant-use trends (specifically methamphetamine and cocaine) were collected from the National Institute on Drug Abuse (NIDA) (1999\u20132021) in the United States for unintentional and intentional deaths. For Canada, opioid- (2016\u20132022) and stimulant-use (2018\u20132022) trends for unintentional and intentional deaths were collected from the Public Health Agency of Canada and the Alberta Substance Use Surveillance System. Joinpoint regression analysis was used to investigate trends for opioid and stimulant use in the United States and Canada. As a proxy for public interest in opioid- and stimulant-related trends, Google Trends Relative Search Interest (RSI) was used to measure the interest over time (2004-present) for opioid- and stimulant-related search terms. Spearman's non-parametric correlation was used to measure the relationship between the RSI and drug-related deaths. Although public attention is mostly directed at the opioid epidemic, stimulant-use is increasing year over year. Moreover, the use of\u00a0stimulants\u00a0and opioids together\u00a0is associated with a higher rate of increase in drug-related deaths each year compared to stimulants or opioids alone. Despite the importance of the potential stimulant contribution to opioid-involved deaths, Google Trends RSI revealed public interest in stimulants has dropped from a peak value in 2004\u20132005, whereas relative interest in opioids is relatively much higher on Google in comparison to the interest in stimulants. Given the contribution of stimulants to the ongoing drug poisoning crisis there is an urgent need to develop and implement strategies that reduce the health risks associated with stimulant use. To achieve this, we must raise awareness among clinicians, policymakers and the general public regarding the potential impacts of stimulant use, including deliberate and unaware co-use of stimulants and opioids, on drug poisoning deaths, population health and the healthcare system.<\/jats:p>","DOI":"10.1371\/journal.pmen.0000319","type":"journal-article","created":{"date-parts":[[2025,7,16]],"date-time":"2025-07-16T17:23:59Z","timestamp":1752686639000},"page":"e0000319","update-policy":"https:\/\/doi.org\/10.1371\/journal.pmen.corrections_policy","source":"Crossref","is-referenced-by-count":2,"title":["Co-involvement of stimulants with opioids in North America: A 'silent epidemic'"],"prefix":"10.1371","volume":"2","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9370-3455","authenticated-orcid":true,"given":"Yutong","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7871-5546","authenticated-orcid":true,"given":"Derek V.","family":"Pierce","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shelly","family":"Vik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0843-4618","authenticated-orcid":true,"given":"Kathryn","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott","family":"Patten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2421-157X","authenticated-orcid":true,"given":"Yanbo","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jake","family":"Hayward","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew J.","family":"Greenshaw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9338-3271","authenticated-orcid":true,"given":"Bo","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2025,7,16]]},"reference":[{"key":"pmen.0000319.ref001","doi-asserted-by":"crossref","first-page":"100437","DOI":"10.1016\/j.lana.2023.100437","article-title":"The continuous opioid death crisis in Canada: changing characteristics and implications for path options forward","volume":"19","author":"B Fischer","year":"2023","journal-title":"The Lancet Regional Health - Americas"},{"key":"pmen.0000319.ref002","article-title":"Drug Overdose Death Rates.","volume-title":"National Institute on Drug Abuse [Internet]","author":"National Institute on Drug Abuse","year":"2023"},{"key":"pmen.0000319.ref003","article-title":"Cost of Injury & Violence.","volume-title":"Centers for Disease Control and Prevention [Internet]","author":"Center for Disease Control and Prevention","year":"2023"},{"issue":"1","key":"pmen.0000319.ref004","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1097\/FTD.0000000000000789","article-title":"Is Europe Facing an Emerging Opioid Crisis Comparable to the U.S.?","volume":"43","author":"J van Amsterdam","year":"2021","journal-title":"Ther Drug Monit"},{"key":"pmen.0000319.ref005","author":"Center for Disease Control and Prevention","year":"2022"},{"key":"pmen.0000319.ref006","doi-asserted-by":"crossref","first-page":"1178632918819440","DOI":"10.1177\/1178632918819440","article-title":"Management of Pain in the United States-A Brief History and Implications for the Opioid Epidemic","volume":"11","author":"SA Bernard","year":"2018","journal-title":"Health Serv Insights"},{"key":"pmen.0000319.ref007","doi-asserted-by":"crossref","first-page":"109001","DOI":"10.1016\/j.drugalcdep.2021.109001","article-title":"Drug overdose deaths involving cocaine and psychostimulants with abuse potential among racial and ethnic groups - United States, 2004-2019","volume":"227","author":"M Kariisa","year":"2021","journal-title":"Drug Alcohol Depend"},{"issue":"9810","key":"pmen.0000319.ref008","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0140-6736(11)61138-0","article-title":"Extent of illicit drug use and dependence, and their contribution to the global burden of disease","volume":"379","author":"L Degenhardt","year":"2012","journal-title":"Lancet"},{"issue":"7","key":"pmen.0000319.ref009","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.3390\/ph3072333","article-title":"The Health Effect of Psychostimulants: A Literature Review","volume":"3","author":"T Favrod-Coune","year":"2010","journal-title":"Pharmaceuticals (Basel)"},{"issue":"17","key":"pmen.0000319.ref010","doi-asserted-by":"crossref","first-page":"388","DOI":"10.15585\/mmwr.mm6817a3","article-title":"Drug Overdose Deaths Involving Cocaine and Psychostimulants with Abuse Potential - United States, 2003-2017","volume":"68","author":"M Kariisa","year":"2019","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"3","key":"pmen.0000319.ref011","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.0242","article-title":"Assessment of Annual Cost of Substance Use Disorder in US Hospitals","volume":"4","author":"C Peterson","year":"2021","journal-title":"JAMA Netw Open"},{"key":"pmen.0000319.ref012","doi-asserted-by":"crossref","first-page":"133","DOI":"10.2147\/SAR.S20895","article-title":"Co-occurring amphetamine use and associated medical and psychiatric comorbidity among opioid-dependent adults: results from the Clinical Trials Network","volume":"2","author":"DJ Pilowsky","year":"2011","journal-title":"Subst Abuse Rehabil"},{"issue":"17","key":"pmen.0000319.ref013","doi-asserted-by":"crossref","first-page":"388","DOI":"10.15585\/mmwr.mm6817a3","article-title":"Drug Overdose Deaths Involving Cocaine and Psychostimulants with Abuse Potential - United States, 2003-2017","volume":"68","author":"M Kariisa","year":"2019","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"1","key":"pmen.0000319.ref014","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s13011-021-00350-5","article-title":"\u201cResurgent\u201d, \u201ctwin\u201d or \u201csilent\u201d epidemic? A select data overview and observations on increasing psycho-stimulant use and harms in North America","volume":"16","author":"B Fischer","year":"2021","journal-title":"Subst Abuse Treat Prev Policy"},{"key":"pmen.0000319.ref015","doi-asserted-by":"crossref","first-page":"805002","DOI":"10.3389\/fpsyt.2021.805002","article-title":"Recent Increase in Methamphetamine Use in a Cohort of Rural People Who Use Drugs: Further Evidence for the Emergence of Twin Epidemics","volume":"12","author":"JR Havens","year":"2022","journal-title":"Front Psychiatry"},{"issue":"1","key":"pmen.0000319.ref016","doi-asserted-by":"crossref","first-page":"2084","DOI":"10.1186\/s12889-022-14506-w","article-title":"Concurrent use of opioids and stimulants and risk of fatal overdose: A cohort study","volume":"22","author":"H Palis","year":"2022","journal-title":"BMC Public Health"},{"key":"pmen.0000319.ref017","doi-asserted-by":"crossref","first-page":"824940","DOI":"10.3389\/fpsyt.2022.824940","article-title":"Patterns of and Rationale for the Co-use of Methamphetamine and Opioids: Findings From Qualitative Interviews in New Mexico and Nevada","volume":"13","author":"BD Rhed","year":"2022","journal-title":"Front Psychiatry"},{"issue":"10","key":"pmen.0000319.ref018","article-title":"The use of google trends in health care research: a systematic review","volume":"9","author":"SV Nuti","year":"2014","journal-title":"PLoS One"},{"key":"pmen.0000319.ref019","author":"Google Trends","year":"2023"},{"issue":"12","key":"pmen.0000319.ref020","doi-asserted-by":"crossref","DOI":"10.2196\/41527","article-title":"Characterizing Help-Seeking Searches for Substance Use Treatment From Google Trends and Assessing Their Use for Infoveillance: Longitudinal Descriptive and Validation Statistical Analysis","volume":"24","author":"T Patton","year":"2022","journal-title":"J Med Internet Res"},{"issue":"11","key":"pmen.0000319.ref021","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0166566","article-title":"Could Google Trends Be Used to Predict Methamphetamine-Related Crime? An Analysis of Search Volume Data in Switzerland, Germany, and Austria","volume":"11","author":"A Gamma","year":"2016","journal-title":"PLoS One"},{"issue":"1","key":"pmen.0000319.ref022","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1159\/000517302","article-title":"Google Trends Data: A Potential New Tool for Monitoring the Opioid Crisis","volume":"28","author":"A Ghosh","year":"2022","journal-title":"Eur Addict Res"},{"issue":"2","key":"pmen.0000319.ref023","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1176\/appi.ps.201700076","article-title":"Communication Strategies to Counter Stigma and Improve Mental Illness and Substance Use Disorder Policy","volume":"69","author":"E McGinty","year":"2018","journal-title":"Psychiatr Serv"},{"key":"pmen.0000319.ref024","author":"Government of Alberta","year":"2023"},{"key":"pmen.0000319.ref025","author":"Public Health Agency of Canada","year":"2023"},{"key":"pmen.0000319.ref026","author":"Statistics Canada","year":"2023"},{"key":"pmen.0000319.ref027","author":"Center for Disease Control and Prevention","year":"2023"},{"issue":"6","key":"pmen.0000319.ref028","first-page":"1","article-title":"Direct standardization (age-adjusted death rates)","author":"LR Curtin","year":"1995","journal-title":"Healthy People 2000 Stat Notes"},{"key":"pmen.0000319.ref029","first-page":"1","article-title":"Age adjustment using the 2000 projected U.S. population","author":"RJ Klein","year":"2001","journal-title":"Healthy People 2010 Stat Notes"},{"key":"pmen.0000319.ref030","author":"Statistics Canada","year":"2018"},{"key":"pmen.0000319.ref031","author":"Google Trends"},{"key":"pmen.0000319.ref032","author":"Google Trends","year":"2023"},{"key":"pmen.0000319.ref033","article-title":"Joinpoint Regression Program.","volume-title":"Joinpoint Trend Analysis Software [Internet]","author":"National Cancer Institute","year":"2023"},{"issue":"9","key":"pmen.0000319.ref034","doi-asserted-by":"crossref","first-page":"1992","DOI":"10.1080\/02664763.2022.2063265","article-title":"Data-driven choice of a model selection method in joinpoint regression","volume":"50","author":"H-J Kim","year":"2022","journal-title":"J Appl Stat"},{"key":"pmen.0000319.ref035","article-title":"Weighted BIC (WBIC).","volume-title":"Joinpoint Help System [Internet]","author":"National Cancer Institute","year":"2022"},{"key":"pmen.0000319.ref036","doi-asserted-by":"crossref","first-page":"918197","DOI":"10.3389\/fpsyt.2022.918197","article-title":"Editorial: A Changing Epidemic and the Rise of Opioid-Stimulant Co-Use","volume":"13","author":"S Ahmed","year":"2022","journal-title":"Front Psychiatry"},{"issue":"6","key":"pmen.0000319.ref037","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.15432","article-title":"The Opioid Crisis-Not Just Opioids Anymore","volume":"5","author":"J Brent","year":"2022","journal-title":"JAMA Netw Open"},{"issue":"3","key":"pmen.0000319.ref038","doi-asserted-by":"crossref","DOI":"10.1001\/jamahealthforum.2021.0273","article-title":"Our Other Epidemic: Addiction","volume":"2","author":"RG Frank","year":"2021","journal-title":"JAMA Health Forum"},{"issue":"3","key":"pmen.0000319.ref039","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.nurpra.2018.12.012","article-title":"Preventing the Next Epidemic: Prescribed Stimulant Abuse","volume":"15","author":"KD Via","year":"2019","journal-title":"The Journal for Nurse Practitioners"},{"key":"pmen.0000319.ref040","doi-asserted-by":"crossref","first-page":"115426","DOI":"10.1016\/j.psychres.2023.115426","article-title":"Off-label stimulant use in US outpatient clinics: Insights from the 2016-2019 National Ambulatory Medical Care Survey","volume":"328","author":"A Rizvi","year":"2023","journal-title":"Psychiatry Res"},{"key":"pmen.0000319.ref041","first-page":"1","article-title":"Chapter One - Interactions between opioids and stimulants: Behavioral pharmacology of abuse-related effects.","volume-title":"Advances in Pharmacology","author":"DR Maguire","year":"2022"},{"issue":"1","key":"pmen.0000319.ref042","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1093\/epirev\/mxaa011","article-title":"The Evolving Overdose Epidemic: Synthetic Opioids and Rising Stimulant-Related Harms","volume":"42","author":"CM Jones","year":"2020","journal-title":"Epidemiologic Reviews"},{"issue":"12","key":"pmen.0000319.ref043","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1001\/jama.2021.1169","article-title":"Continued Increases in Overdose Deaths Related to Synthetic Opioids: Implications for Clinical Practice","volume":"325","author":"GT Baldwin","year":"2021","journal-title":"JAMA"},{"key":"pmen.0000319.ref044","author":"Centers for Medicare & Medicaid Services","year":"2023"},{"key":"pmen.0000319.ref045","author":"L Hatt","year":"2022"},{"issue":"1","key":"pmen.0000319.ref046","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.pop.2010.11.004","article-title":"Stimulant abuse: pharmacology, cocaine, methamphetamine, treatment, attempts at pharmacotherapy","volume":"38","author":"D Ciccarone","year":"2011","journal-title":"Prim Care"},{"key":"pmen.0000319.ref047","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1146\/annurev.publhealth.012809.103600","article-title":"The methamphetamine problem in the United States","volume":"31","author":"R Gonzales","year":"2010","journal-title":"Annu Rev Public Health"},{"key":"pmen.0000319.ref048","author":"Drug Enforcement Administration","year":"2006"},{"key":"pmen.0000319.ref049","author":"Government of Canada D of J","year":"2007"},{"key":"pmen.0000319.ref050","volume-title":"Chapter 7 Vision For the Future: A Public Health Approach. Facing Addiction in America: The Surgeon General\u2019s Report on Alcohol, Drugs, and Health [Internet]","author":"Substance Abuse and Mental Health Services Administration (US)","year":"2016"},{"issue":"4","key":"pmen.0000319.ref051","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1111\/cch.12558","article-title":"Does integrated academic and health education prevent substance use? Systematic review and meta-analyses","volume":"44","author":"GJ Melendez-Torres","year":"2018","journal-title":"Child Care Health Dev"},{"issue":"1","key":"pmen.0000319.ref052","first-page":"25","article-title":"Prevention of substance abuse: a brief overview","volume":"4","author":"ME Medina-Mora","year":"2005","journal-title":"World Psychiatry"},{"issue":"3","key":"pmen.0000319.ref053","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1093\/sw\/49.3.343","article-title":"Adolescent substance use: reviewing the effectiveness of prevention strategies","volume":"49","author":"D Skiba","year":"2004","journal-title":"Soc Work"},{"key":"pmen.0000319.ref054","doi-asserted-by":"crossref","first-page":"108384","DOI":"10.1016\/j.drugalcdep.2020.108384","article-title":"Overdose deaths involving psychostimulants with abuse potential, excluding cocaine: State-level differences and the role of opioids","volume":"218","author":"M Cano","year":"2021","journal-title":"Drug Alcohol Depend"},{"issue":"1","key":"pmen.0000319.ref055","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1111\/j.1360-0443.2011.03601.x","article-title":"The effectiveness of interventions for reducing stigma related to substance use disorders: a systematic review","volume":"107","author":"JD Livingston","year":"2012","journal-title":"Addiction"},{"issue":"1","key":"pmen.0000319.ref056","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/s13012-023-01297-w","article-title":"Implementing contingency management for stimulant use in opioid treatment programs: protocol of a type III hybrid effectiveness-stepped-wedge trial","volume":"18","author":"SJ Becker","year":"2023","journal-title":"Implement Sci"},{"issue":"5","key":"pmen.0000319.ref057","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1192\/pb.bp.110.031831","article-title":"Contingency management: what it is and why psychiatrists should want to use it","volume":"35","author":"NM Petry","year":"2011","journal-title":"Psychiatrist"},{"issue":"6","key":"pmen.0000319.ref058","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0234809","article-title":"Treatment of stimulant use disorder: A systematic review of reviews","volume":"15","author":"C Ronsley","year":"2020","journal-title":"PLoS One"},{"issue":"1","key":"pmen.0000319.ref059","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1186\/s12889-022-12678-z","article-title":"Polysubstance use poisoning deaths in Canada: an analysis of trends from 2014 to 2017 using mortality data","volume":"22","author":"S Konefal","year":"2022","journal-title":"BMC Public Health"}],"container-title":["PLOS Mental Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pmen.0000319","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,16]],"date-time":"2025-07-16T17:24:06Z","timestamp":1752686646000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pmen.0000319"}},"subtitle":[],"editor":[{"given":"Craig Nicholas","family":"Cumming","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2025,7,16]]},"references-count":59,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2025,7,16]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pmen.0000319","relation":{},"ISSN":["2837-8156"],"issn-type":[{"value":"2837-8156","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,16]]}}}